Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis

详细信息    查看全文

• 作者：Eduard Koman ; Ashwani Gupta ; Faiz Subzposh…
• 关键词：Subcutaneous implantable cardioverter ; defibrillator ; Implantable cardioverter ; defibrillator ; End ; stage renal disease ; Hemodialysis
• 刊名：Journal of Interventional Cardiac Electrophysiology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：45
• 期：2
• 页码：219-223
• 全文大小：528 KB
• 参考文献：1.Asif, A., Salman, L., Lopera, G., Haqqie, S. S., & Carrillo, R. (2012). Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination. Seminars in Dialysis, 25, 582–586.CrossRef PubMed
  2.Bloom, H., Heeke, B., Leon, A., Mera, F., Delurgio, D., Beshai, J., & Langberg, J. (2006). Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing and Clinical Electrophysiology, 29, 142–145.CrossRef PubMed
  3.Tompkins, C., McLean, R., Cheng, A., Brinker, J. A., Marine, J. E., Nazarian, S., Spragg, D. D., Sinha, S., Halperin, H., Tomaselli, G. F., Berger, R. D., Calkins, H., & Henrikson, C. A. (2011). End-stage renal disease predicts complications in pacemaker and ICD implants. Journal of Cardiovascular Electrophysiology, 22(10), 1099–1104.CrossRef PubMed
  4.Brunner, M. P., Cronin, E. M., Duarte, V. E., et al. (2014). Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. Heart Rhythm, 11, 799–805.CrossRef PubMed
  5.Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., Smith, W., & Burke, M. C. (2013). Safety and efficacy of a totally subcutaneous implantable cardioverter-defibrillator. Circulation, 128, 944–953.CrossRef PubMed
  6.Lambiase, P. D., Barr, C., Theuns, D. A. M. J., Knops, R., Neuzil, P., Johansen, J. B., Hood, M., Pederson, S., Kaab, S., Murgatroyd, F., Reeve, H. L., Carter, N., Boersma, L., & EFFORTLESS investigators. (2014). Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. European Heart Journal, 35, 1657–1665.PubMedCentral CrossRef PubMed
  7.Burke, M. C., Gold, M. R., Knight, B. P., Barr, C. S., et al. (2015). Safety and efficacy of the totally subcutaneous implantable defibrillator: 2 year results from pooled analysis of the IDE study and EFFORTLESS registry. Journal of the American College of Cardiology, 65(16), 1605–1615.CrossRef PubMed
  8.El-Chami, M. F., Levy, M., Kelli, H. M., Casey, M., Hoskins, M. H., Goyal, A., Langberg, J. J., Patel, A., Delurgio, D., Lloyd, M. S., Leon, A. R., & Merchant, M. F. (2015). Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients with end-stage renal disease on dialysis. Journal of Cardiovascular Electrophysiology, 26(8), 900–904.CrossRef PubMed
  9.Herzog, C. A., Mangrum, J. M., & Passman, R. (2008). Sudden cardiac death and dialysis patients. Seminars in Dialysis, 21, 300–307.CrossRef PubMed
  10.Pun, P. H., Hellkamp, A. S., Sanders, G. D., et al. (2015). Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrology, Dialysis, Transplantation, 30(5), 829–835.CrossRef PubMed
  11.Dhamija, R. K., Tan, H., Philbin, E., Mathew, R. O., Sidhu, M. S., Wang, J., Saour, B., Haqqie, S. S., Beathard, G., Yevzlin, A. S., Salman, L., Boden, W. E., Siskin, G., & Asif, A. (2015). Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. American Journal of Kidney Diseases, 66(1), 154–158.CrossRef PubMed
  12.Hess, P. L., Hellkamp, A. S., Peterson, E. D., et al. (2014). Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. Circulation. Arrhythmia and Electrophysiology, 7, 793–799.PubMedCentral CrossRef PubMed
  
• 作者单位：Eduard Koman (1)
  Ashwani Gupta (2)
  Faiz Subzposh (2)
  Heath Saltzman (2)
  Steven P Kutalek (2)
  
  1. Department of Internal Medicine, Drexel University College of Medicine, New College Building 245 N. 15th Street, 6th Floor, Philadelphia, PA, 19102, USA
  2. Division of Cardiac Electrophysiology, Drexel University College of Medicine, Philadelphia, PA, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1572-8595

文摘

Background Subcutaneous implantable cardioverter-defibrillator (S-ICD) provides potential benefits in patients on hemodialysis (HD) by reducing the risk of blood stream infection and preserving vascular access sites. We evaluated the safety and efficacy of S-ICD in patients with end-stage renal disease (ESRD) on HD.